|Articles|May 27, 2016
Valeant Rejected Takeda Bid
May 27, 2016.
Advertisement
Reuters reports that Valeant Pharmaceuticals rejected a joint takeover offer from Japan's Takeda and TPG Capital Management this spring.
The offer was reportedly made a few weeks before Joseph Papa took over as Valeant's new chief executive in April.
More on the story
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Capital Flows into Pharma with Funding Rounds and Loan Facilities
2
Beyond Skill-Building: Insights for C-Suite Leaders on Attracting, Developing, and Retaining the Best Possible Workforce
3
Roundup: Biopharmaceutical Industry Activity Accelerates with Focus on Rare Diseases and Novel Therapies
4
The Situation We Faced: The Hard Lessons of Scaling Stem Cell Production
5
